OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma
Jialei Weng, Shaoqing Liu, Qiang Zhou, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006655-e006655
Open Access | Times Cited: 23
Jialei Weng, Shaoqing Liu, Qiang Zhou, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006655-e006655
Open Access | Times Cited: 23
Showing 23 citing articles:
Integrating single-cell RNA and T cell/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age
Yufei Wang, Ronghong Li, Renyang Tong, et al.
Nature Immunology (2025)
Open Access | Times Cited: 4
Yufei Wang, Ronghong Li, Renyang Tong, et al.
Nature Immunology (2025)
Open Access | Times Cited: 4
ANXA3-Rich Exosomes Derived from Tumor-Associated Macrophages Regulate Ferroptosis and Lymphatic Metastasis of Laryngeal Squamous Cell Carcinoma
Licheng Xu, Wenjing Li, Danxi Liu, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 5, pp. 614-630
Closed Access | Times Cited: 13
Licheng Xu, Wenjing Li, Danxi Liu, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 5, pp. 614-630
Closed Access | Times Cited: 13
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes
Rui Hu, Jing Li, Qi Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118400-118400
Closed Access | Times Cited: 6
Rui Hu, Jing Li, Qi Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118400-118400
Closed Access | Times Cited: 6
Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma
Zongbo Dai, Yu Wang, Ning Sun, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Zongbo Dai, Yu Wang, Ning Sun, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
ARL8B regulates lysosomal function and predicts poor prognosis in hepatocellular carcinoma
Liyan Wu, Zelin Weng, Xia Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Liyan Wu, Zelin Weng, Xia Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade
Boyu Sun, Ziyu Xun, Nan Zhang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Boyu Sun, Ziyu Xun, Nan Zhang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study
Lixia Yi, Ning Zhang, Li Xu, et al.
ESMO Open (2024) Vol. 9, Iss. 2, pp. 102239-102239
Open Access | Times Cited: 4
Lixia Yi, Ning Zhang, Li Xu, et al.
ESMO Open (2024) Vol. 9, Iss. 2, pp. 102239-102239
Open Access | Times Cited: 4
Protein palmitoylation in hepatic diseases: Functional insights and therapeutic strategies
Ying Wang, Haoyuan Ma, Bowen Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Ying Wang, Haoyuan Ma, Bowen Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Melatonin protects aged oocytes from depalmitoylation-mediated quality reduction by promoting PPT1 degradation and antioxidation
Rujun Ma, Mengqi Xue, Fahuan Ge, et al.
Redox Biology (2025) Vol. 80, pp. 103510-103510
Open Access
Rujun Ma, Mengqi Xue, Fahuan Ge, et al.
Redox Biology (2025) Vol. 80, pp. 103510-103510
Open Access
Advances in Palmitoylation: A key Regulator of liver cancer development and therapeutic targets
Zilong Zhu, Shenghui Feng, Anqi Zeng, et al.
Biochemical Pharmacology (2025), pp. 116810-116810
Closed Access
Zilong Zhu, Shenghui Feng, Anqi Zeng, et al.
Biochemical Pharmacology (2025), pp. 116810-116810
Closed Access
iMetAct: An integrated systematic inference of metabolic activity for dissecting tumor metabolic preference and tumor-immune microenvironment
Binxian Wang, Chao Huang, Xuan Liu, et al.
Cell Reports (2025) Vol. 44, Iss. 3, pp. 115375-115375
Open Access
Binxian Wang, Chao Huang, Xuan Liu, et al.
Cell Reports (2025) Vol. 44, Iss. 3, pp. 115375-115375
Open Access
Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single‐Cell RNA Sequencing
Lujuan Ma, Yu Luan, Lin Lü
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Lujuan Ma, Yu Luan, Lin Lü
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models
Romain Désert, Fabio Gianonne, Antonio Saviano, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access
Romain Désert, Fabio Gianonne, Antonio Saviano, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access
Development of an efficient liposomal DOX delivery formulation for HCC therapy by targeting CK2α
Ruixia Zhao, Sinan Cheng, Xue Bai, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 4
Closed Access | Times Cited: 2
Ruixia Zhao, Sinan Cheng, Xue Bai, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 4
Closed Access | Times Cited: 2
Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis
Yanwei Ji, Qi An, Xinyu Wen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 2
Yanwei Ji, Qi An, Xinyu Wen, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 2
Remodeling the hepatic immune microenvironment and demolishing T cell traps to enhance immunotherapy efficacy in liver metastasis
Zhenyu Luo, Mengshi Jiang, Ningtao Cheng, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 890-904
Closed Access | Times Cited: 1
Zhenyu Luo, Mengshi Jiang, Ningtao Cheng, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 890-904
Closed Access | Times Cited: 1
The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system
Qiaona Wang, Yunshou Lin, Wenguan Yu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Qiaona Wang, Yunshou Lin, Wenguan Yu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Single-cell multi-omics in the study of digestive system cancers
Shuang Zhou, Nanfei Lin, Liying Yu, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 23, pp. 431-445
Open Access | Times Cited: 2
Shuang Zhou, Nanfei Lin, Liying Yu, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 23, pp. 431-445
Open Access | Times Cited: 2
TREM1+ tumor-associated macrophages secrete CCL7 to promote hepatocellular carcinoma metastasis
Simin Huang, Longguang He, Yufei Zhao, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access
Simin Huang, Longguang He, Yufei Zhao, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access
Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma
Kangqiang Peng, Xiao Zhang, Zhongliang Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Kangqiang Peng, Xiao Zhang, Zhongliang Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Cancer immunotherapeutic challenges from autophagy-immune checkpoint reciprocal regulation
Gang Zhang, Yinfeng Chen, Xing Huang, et al.
Trends in cancer (2024)
Closed Access
Gang Zhang, Yinfeng Chen, Xing Huang, et al.
Trends in cancer (2024)
Closed Access
Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization
Xie Shuangshuang, Cuiyun Wang, Xiaoyan Liu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 9
Open Access
Xie Shuangshuang, Cuiyun Wang, Xiaoyan Liu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 9
Open Access
